1 |
Korean Pediatric Society, Committee on Infectious Diseases. Guideline for immunization in Korean infants and children. 5th edition, Kwang Moon Press, Seoul, Korea, 2002 p181-203
|
2 |
Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB, et al. Gambian Pneumococcal Vaccine Trial Group. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia : randomised, double-blind, placebocontrolled trial. Lancet 2005;365:1139-46
DOI
ScienceOn
|
3 |
Black S, Shinefield H, Baxter R, Austrian R, Bracken L, Hansen J, et al. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J 2004;23:485-9
DOI
ScienceOn
|
4 |
Regev-Yochay G, Dagan R, Raz M, Carmeli Y, Shainberg B, Derazne E, et al. Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in children. JAMA 2004;292:716-20
DOI
ScienceOn
|
5 |
Fireman B, Black SB, Shinefield HR, Lee J, Lewis E, Ray P. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J 2003;22:10-6
DOI
ScienceOn
|
6 |
Moore M, Park S, Hennessy T. Impact of a PCV7 vaccine on carriage of nonsuceptible pneumococci in urban Alaska children. Paper presented at : 4th International Symposium on Pneumococci and Pneumococcal Diseases; 2004; Helsinki, Finland
|
7 |
Rennels MB, Edwards KM, Keyserling HL, Reisinger KS, Hogerman DA, Madore DV. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. Pediatrics 1998;101:604-11
DOI
ScienceOn
|
8 |
Kyaw MH. National trends in antibiotic resistant invasive pneumococcal disease in the conjugate vaccine era. Paper presented at : 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy; 2003; Chicago, IL. Abstract G-2045
|
9 |
Dagan R. The potential effect of widespread use of pneumococcal conjugate vaccines on the practice of pediatric otolaryngology : the case of acute otitis media. Current Opinion in Otolaryngology & Head and Neck Surgery 2004; 12:488-94
DOI
ScienceOn
|
10 |
O'Brien KL, Moulton LH, Reid R, Weatherholtz R, Oski J, Brown L, et al. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children : group randomised trial. Lancet 2003;362:355-61
DOI
ScienceOn
|
11 |
Porat N, Barkai G, Jacobs MR, Trefler R, Dagan R. Four antibiotic resistant S. pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel. J Infect Dis 2004;189:385-92
DOI
ScienceOn
|
12 |
O'Brien KL, Santosham M. Potential impact of conjugate pneumococcal vaccines on pediatric pneumococcal diseases. Am J Epidemiol 2004;159:634-44
DOI
ScienceOn
|
13 |
Dagan R, Givon-Lavi N, Zamir O, Fraser D. Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers. Pediatr Infect Dis J 2003;22:532-40
DOI
|
14 |
Madhi SA, Klugman KP : Vaccine Trialist Group. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 2004;10:811-3
DOI
ScienceOn
|
15 |
Pai R, Moore MR, Pilishvili T, Gertz RE, Whitney CG, Beall B, et al. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis 2005;192:1988-95
DOI
ScienceOn
|
16 |
Schuchat A, Flannery B, Heffernan R. Invasive pneumococcal disease in HIV-AIDS : has introduction of 7-valent pneumococcal conjugate vaccine(PCV-7) reduced HIVrelated disease burden in the US? Paper presented at : 4th International Symposium on Pneumococci and Pneumococcal Diseases; 2004; Helsinki, Finland. Abstract EPI-05, May 9-13, 2004
|
17 |
Kilpi T, Ahman H, Jokinen J, Lankinen KS, Palmu A, Savolainen H. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children : randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin Infect Dis 2003;37:1155-64
DOI
ScienceOn
|
18 |
Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N, et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003;349:1341-8
DOI
ScienceOn
|
19 |
Dagan R, Jacobs MR, Greenberg D. Pneumococcal infections. In : Feigin RD, Cherry JD, Demmler GJ, Kaplan S (eds). Textbook of Pediatric Infectious Diseases. 5th ed. Vol. 1. Philadelphia : WB Saunders; 2004:1204-58
|
20 |
Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003;348:1737-46
DOI
ScienceOn
|
21 |
Dagan R, Melamed R, Muallem M, Piglansky L, Greenberg D, Abramson O, et al. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis 1996;174:1271-8
DOI
ScienceOn
|
22 |
Dagan R, Sikuler-Cohen M, Zamir O, Janco J, Givon-Lavi N, Fraser D. Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees. Pediatr Infect Dis J 2001; 20:951-8
DOI
ScienceOn
|
23 |
Shinefield HR, Black S, Ray P, Chang I, Lewis N, Fireman B. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. Pediatr Infect Dis J 1999;18:757-63
DOI
ScienceOn
|
24 |
Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001;344:403-9
DOI
ScienceOn
|
25 |
Centers for Disease Control. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2000;46:1-24
|
26 |
Lee HJ. Pneumococcal protein conjugate vaccine. Korean J Pediatr Infect Dis 2000;7:20-30
|
27 |
O'Brien KL, Dagan R. The potential indirect effect of conjugate pneumococcal vaccines. Vaccine 2003;21:1815-25
DOI
ScienceOn
|
28 |
Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000;19:187-95
DOI
ScienceOn
|
29 |
Bogaert D, van Belkum A, Sluijter M, Luijendijk A, de Groot R, Rumke HC. et al. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 2004;363:1871-2
DOI
ScienceOn
|
30 |
Veenhoven R, Bogaert D, Uiterwaal C, Brouwer C, Kiezebrink H, Bruin J. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media : a randomized study. Lancet 2003; 361:2189-95
DOI
ScienceOn
|
31 |
Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation : the key to pneumococcal disease. Lancet Infect Dis 2004;4:144-54
DOI
ScienceOn
|
32 |
Lee HJ. Immunogenicity and safety of pneumococcal protein conjugate vaccine. Korean J Pediatr Infect Dis 2003;10;145-52
DOI
|
33 |
Givon-Lavi N, Fraser D, Dagan R. Vaccination of day-care center attendees reduces carriage of Streptococcus pneumoniae among their younger siblings. Pediatr Infect Dis J 2003;22:524-32
DOI
|
34 |
American Academy of Pediatrics, Committee on Infectious Diseases. Policy statement : recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine(Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 2000;106:362-6
DOI
ScienceOn
|